Sank Leonard 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Sank Leonard
Director
Transactions
- Award
Common Stock
2022-07-28+12,000→ 18,000 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]The reporting person previously reported and disclaimed beneficial ownership over 138,889 shares of common stock owned by a company wholly owned by a trust of which the reporting person was previously a trustee. The reporting person resigned as a trustee of such trust, effective February 3, 2022.